Did You Attend An Event at AAOMS?
President’s Event at Universal Orlando Resort, Keynote Lecture to Explore ‘Impossible Science’, Eat, Drink and Be Industry-Educated Sessions, or Happy Hour in the Hall?
Read MoreSep 19, 2024
President’s Event at Universal Orlando Resort, Keynote Lecture to Explore ‘Impossible Science’, Eat, Drink and Be Industry-Educated Sessions, or Happy Hour in the Hall?
Read MoreSep 4, 2024
This years AAOMS annual meeting will include on-demand sessions that will be available starting on September 9, 2024.
Read MoreSep 4, 2024
Back by popular demand! Attendees are invited to join the fun by participating in AAOMSopoly, an exciting Exhibit Hall game available on the Annual Meeting mobile app.
Read MoreSep 4, 2024
President’s Event at Universal Orlando Resort, Keynote Lecture to Explore ‘Impossible Science’, Eat, Drink and Be Industry-Educated Sessions, or Happy Hour in the Hall?
Read MoreAug 20, 2024
Do you remember the HCC research presented at ASCO 2024? Test your knowledge and see how you rank!
Read MoreAug 20, 2024
Do you remember the eNSCLC research presented at ASCO 2024? Test more of your knowledge with new questions and see how you rank!
Read MoreAug 20, 2024
Do you remember the CLL research presented at ASCO 2024? Test your knowledge with new questions and see how you rank!
Read MoreAug 16, 2024
Do you remember the CLL research presented at ASCO 2024? Test your knowledge now and see how you rank!
Read MoreAug 16, 2024
Do you remember the eNSCLC research presented at ASCO 2024? Test your knowledge now and see how you rank!
Read MoreAug 7, 2024
A curated eBook featuring ASCO 2024 eNSCLC-focused studies, findings, and expert opinions.
Read MoreAug 7, 2024
A curated eBook featuring ASCO 2024 CLL-focused studies, findings, and expert opinions.
Read MoreAug 7, 2024
A curated eBook featuring ASCO 2024 HCC-focused studies, findings, and expert opinions.
Read MoreJul 25, 2024
CTNNB1 alterations affect outcomes in patients with hepatocellular carcinoma (HCC).
Read MoreJul 25, 2024
Biomarker tests for non-small lung cancer (NSCLC) improve patient outcomes, but they are not available to everyone.
Read MoreJul 24, 2024
Researchers evaluated whether targeted next-generation sequencing was comparable to fluorescence in situ hybridization for detecting genetic alterations in CLL.
Read MoreJul 18, 2024
Do you remember the multiple myeloma research presented at ASCO 2024? Test your knowledge now and see how you rank!
Read MoreJul 17, 2024
A curated eBook featuring ASCO 2024 multiple myeloma-focused studies, findings, and expert opinions.
Read MoreJul 16, 2024
Adding BCR kinase inhibitor ibrutinib or idelalisib to monoclonal antibody pembrolizumab increases treatment efficacy in CLL with Richter transformation.
Read MoreJul 15, 2024
An increasing number of patients with eNSCLC currently have access to biomarker testing and targeted therapies, according to the MYLUNG consortium.
Read MoreJul 15, 2024
Immerse yourself in retinal science advancements, therapeutics, innovation and fellowship at the 42nd ASRS Annual Scientific Meeting July 17-20, 2024.
Read More